PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.825
Bid: 1.80
Ask: 1.85
Change: -0.173 (-8.66%)
Spread: 0.05 (2.778%)
Open: 1.825
High: 1.85
Low: 1.825
Prev. Close: 1.998
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

Mon, 20th Mar 2023 08:53

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil.

"It is not yet known exactly where more pain will emerge in the banking sector, but investors fear the problems are not yet over," said Susannah Streeter, head of money and markets at Hargreaves Lansdown.

The FTSE 100 index opened down 115.03 points, 1.6%, at 7,220.37. The FTSE 250 was down 405.08 points, or 2.2%, at 18,065.75, and the AIM All-Share was down 9.52 points, or 1.2%, at 794.51.

The Cboe UK 100 was down 1.5% at 722.97, the Cboe UK 250 was down 2.1% at 15,697.40, and the Cboe Small Companies was down 1.6% at 12,644.51.

UBS will take over its troubled Swiss rival Credit Suisse for USD3.25 billion following crunch talks on Sunday aimed at stopping the stricken bank from triggering a wider international banking crisis.

The Swiss government said the deal, involving Switzerland's biggest bank taking over the second-largest, was vital to prevent irreparable economic turmoil spreading throughout the country and beyond.

Michael Hewson, chief market analyst at CMC Markets, said: "Some have suggested that UBS putting such a low-ball number on its interest means that Credit Suisse could be in more trouble than perhaps regulators are letting on, and while that might be true, it could also be UBS management being extremely cautious."

Shares in UBS were 15% lower in Zurich on Monday morning. The bank has a market capitalisation of CHF53.17 billion. Shares in Credit Suisse plunged 63% for a market cap of just CHF2.78 billion, about USD2.99 billion.

The acquisition was welcomed in Washington, Brussels and London as one that would support financial stability.

The Bank of England has insisted the financial system in the UK remains "safe and sound", in an effort to calm fears after the emergency sale.

The pound was quoted at USD1.2170 at early on Monday in London, virtually unchanged compared to USD1.2168 at the London equities close on Friday.

In European equities on Monday, the CAC 40 in Paris was down 0.8%, while the DAX 40 in Frankfurt was down 1.0%.

France's central bank chief sought to distance European and French banks from the problems at Credit Suisse and banking woes in the US.

Credit Suisse and the banking volatility in the US "don't concern French and European banks", Francois Villeroy de Galhau, a member of the European Central Bank's governing council, told France Inter radio.

The euro stood at USD1.0636, lower from USD1.0665 late Friday. Against the yen, the dollar was trading at JPY130.69, down from JPY132.12.

Francesco Pesole at ING said he expects the yen to stay in demand for now amid the current risk-off market backdrop.

The US Federal Reserve and other major central banks are making a coordinated effort to improve banks' access to liquidity. The special drive will be launched on Monday by the Fed and the central banks of Canada, the UK, Japan, the EU and Switzerland.

The move comes after the US banking regulator struck a deal to sell most of the assets of the failed Signature Bank to another institution on Sunday.

Signature Bank was seized by the Federal Deposit Insurance Corp a week ago after it imploded in the wake of the collapse of Silicon Valley Bank earlier in March. The FDIC is seeking a similar deal to sell off parts of SVB, according to Bloomberg.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The next few hours of trading will give us a better picture on whether the crisis is contained."

In London, banking stocks were the worst performers in early morning trade. Barclays was down 7.4%, Standard Chartered down 8.0%, NatWest down 7.8%, and Lloyds down 4.6%. HSBC, which last week bought the UK arm of SVB, was 5.1% lower.

Conversely, mining stocks were some of Monday's top performers, with Fresnillo up 3.3% and Endeavour Mining up 6.2%.

Separately, the UK water services regulation authority Ofwat on Monday announced new powers that will enable it to stop the payment of dividends by water utilities if they would "risk the company's financial resilience". It said it would also take enforcement action against water companies that don't link dividend payments to performance.

Ofwat said the change will require company board to "take account of their performance" for customers and the environment when deciding to make dividend payments and will require companies to "maintain a higher level of overall financial health".

Water utilities were higher in early morning trade, with investors perhaps fearing worse from the regulator amid growing political pressure following the repeated release of sewage into UK rivers. United Utilities was up 1.2%, Severn Trent up 1.3%, and Pennon up 0.3%.

Elsewhere in the FTSE 100, Intertek was down 0.4%. The product testing, inspecting and certification firm announced the promotion of Colm Deasy to chief financial officer.

Deasy replaces Jonathan Timmis who has stepped down with immediate effect, with no reason provided by the company for his departure.

In the FTSE 250, FirstGroup fell 1.4% despite announcing it extended the current arrangements for its West Coast partnership rail contract with the UK Department for Transport.

The arrangements were set to expire on March 31 and have now been extended to October 15, "broadly" under the same terms and conditions, the public transport provider said.

The contract comprises of the operation of Avanti West Coast and the shadow operation of the HS2 programme.

On AIM, Genedrive jumped 8.1% after it announced that its MT-RNR1 ID kit is in process for roll out at two further hospital sites in the Greater Manchester.

Genedrive's MT-RNR1 ID kit is a commercial point-of-care genetic test that helps to avoid irreversible lifelong hearing loss in specific infants exposed to aminoglycosides antibiotics by detecting a gene variant that can cause deafness, allowing for alternative antibiotics to be prescribed.

In Asia on Monday, the Japanese Nikkei 225 index closed down 1.4%. In China, the Shanghai Composite closed down 0.5%, while the Hang Seng index in Hong Kong finished down 2.7%. The S&P/ASX 200 in Sydney lost 1.4%.

China's central bank left its interest rates unchanged. The People's Bank of China said it held its one-year loan prime rate - which serves as a benchmark for corporate loans - at 3.65%. The five-year rate also remained at 4.3%.

It was the seventh successive month that the PBoC left rates unchanged. The move had been anticipated by the market, according to FXStreet-cited consensus.

In the US on Friday, Wall Street ended lower, with the Dow Jones Industrial Average down 1.2%, the S&P 500 down 1.1% and the Nasdaq Composite down 0.7%.

Brent oil was quoted at USD70.26 a barrel early in London on Monday, down from USD73.43 late Friday. Gold was quoted at USD2,004.05 an ounce, sharply higher against USD1,957.76.

Naeem Aslam, chief investment officer at Zaye Capital Markets, said the yellow metal remains in demand because investors believe that banks are not out of the woods yet.

"Traders always prefer safe haven in a situation like this as the contagion risk is always very high," Aslam said.

Still to come in Monday's economic calendar, there is a US retail trade report at 1400 GMT.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 Jun 2023 10:49

Genedrive secures multi-partner grant award

(Sharecast News) - Molecular diagnostics specialist Genedrive announced its involvement in a multi-partner grant award called DEVOTE on Friday, supported by Innovate UK and the UK government's Innovation Accelerator programme.

Read more
16 Jun 2023 10:29

AIM WINNERS & LOSERS: Marlowe up on report of potential division sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jun 2023 09:27

IN BRIEF: Genedrive shares up as UK government grant received

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Awarded a multi-partner grant for the validation of its CYP2X19 ID kit from Innovate UK and the UK government Innovation Accelerator programme. Says the 'Devote' grant will allow it to offer critical clinical tests in NHS settings.

Read more
19 May 2023 16:03

Genedrive jumps on draft NICE testing guidance

(Sharecast News) - Point-of-care molecular diagnostics company Genedrive announced on Friday that the UK's National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of CYP2C19 genotyping before administering clopidogrel in the management of ischemic stroke (IS) patients.

Read more
19 May 2023 10:24

Genedrive says NICE committee recommends CYP2C19 for stroke patients

(Alliance News) - Genedrive PLC on Friday said draft guidance from the UK's National Institute for Health & Care Excellence has recommended that CYP2C19 genotyping should be used to manage ischemic stroke patients.

Read more
19 May 2023 10:15

AIM WINNERS & LOSERS: iEnergizer to depart; Unbound for sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
4 May 2023 16:11

UK shareholder meetings calendar - next 7 days

Friday 5 May 
abrdn Smaller Companies Income Trust PLCAGM
Holders Technology PLCAGM
HSBC Holdings PLCAGM
InterContinental Hotels Group PLCAGM
James Fisher & Sons PLCAGM
Man Group PLCAGM
Rightmove PLCAGM
UK Oil & Gas PLCAGM
Monday 8 May 
no events scheduled 
Tuesday 9 May 
Caledonia Mining Corp PLCAGM
Direct Line Insurance Group PLCAGM
Foxtons Group PLCAGM
Hostelworld Group PLCAGM
IWG PLCAGM
Just Group PLCAGM
Midwich Group PLCAGM
Osirium Technologies PLCAGM
Windward LtdAGM
Wednesday 10 May 
abrdn PLCAGM
Antofagasta PLCAGM
Cenkos Securities PLCAGM
Ecora Resources PLCAGM
H&T Group PLCAGM
Harbour Energy PLCAGM
Jupiter Fund Management PLCAGM
Literacy Capital PLCAGM
Luceco PLCAGM
Marshalls PLCAGM
National Express Group PLCAGM
Renewables Infrastructure Group LtdAGM
Rentokil Initial PLCAGM
Seplat Energy PLCAGM
Spirax-Sarco Engineering PLCAGM
TClarke PLCAGM
Thursday 11 May 
88 Energy LtdAGM
Cairn Homes PLCAGM
Capita PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Eleco PLCAGM
Eurocell PLCAGM
FBD Holdings PLCAGM
Genedrive PLCGM re Equity Prepayment Facility
Genel Energy PLCAGM
Gresham House PLCAGM
Gym Group PLCAGM
Hiscox LtdAGM
Irish Continental Group PLCAGM
John Wood Group PLCAGM
MyHealthChecked PLCAGM
OSB Group PLCAGM
Poolbeg Pharma PLCAGM
Rolls-Royce Holdings PLCAGM
Serinus Energy PLCAGM
Uniphar PLCAGM
Videndum PLCAGM
WAG Payment Solutions PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Mar 2023 20:33

IN BRIEF: Genedrive sees acceleration of revenue in 2023

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Reports revenue in the six months to December 31 of GBP20,000 compared to nothing a year prior, and an operating loss of GBP2.7 million from GBP2.8 million. Confident that the company will see an acceleration of revenues through 2023 and going forwards. Agrees GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd with an initial drawn amount of GBP2 million, expected to be received in early April. Proceeds will be used towards the commercialisation of the antibiotic induced hearing loss test, Genedrive MT-RNR1 ID Kit and enhancing the Genedrive platform as well as providing additional working capital. Directors believe the facility is the best option available at present.

Read more
30 Mar 2023 11:18

Genedrive MT-RNR1 ID kit receives final UK NICE recommendation for NHS

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence ratified and finalised its recommendation that Genedrive's hearing loss gene screening test MT-RNR1 ID kit can be used by the NHS.

Read more
30 Mar 2023 07:57

LONDON BRIEFING: Stocks add to rebound; SSE ups earnings guidance

(Alliance News) - Stocks in London are set to build on Wednesday's gains, as risk appetite recovers following the recent banking turmoil.

Read more
20 Mar 2023 09:37

AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Mar 2023 09:21

Genedrive to roll out hearing loss screening in two NHS sites

(Alliance News) - Genedrive PLC on Monday reported further progress in the rollout of its hearing loss gene screening test in the UK.

Read more
9 Feb 2023 12:05

LONDON MARKET MIDDAY: Standard Chartered takeover talks lift FTSE 100

(Alliance News) - Stock prices in London were largely higher at midday on Thursday, thanks to a strong set of results from drug maker AstraZeneca and renewed takeover talks for lender Standard Chartered.

Read more
9 Feb 2023 11:19

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.